Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-25-328684
Filing Date
2025-12-22
Accepted
2025-12-22 16:01:27
Documents
10
Period of Report
2025-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A sln-20251214.htm   iXBRL 8-K/A 58615
  Complete submission text file 0001193125-25-328684.txt   214420

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sln-20251214.xsd EX-101.SCH 56128
12 EXTRACTED XBRL INSTANCE DOCUMENT sln-20251214_htm.xml XML 7243
Mailing Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP
Business Address 12 HAMMERSMITH GROVE OFFICE 205 LONDON United Kingdom W6 7AP 44-0-20-3457 6900
Silence Therapeutics plc (Filer) CIK: 0001479615 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0
Type: 8-K/A | Act: 34 | File No.: 001-39487 | Film No.: 251592370
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)